Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns. - Wikidata - awgldk - TriplyDB

Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.

Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.

http://www.wikidata.org/entity/Q34108244

about

Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides Burn wounds infected with Pseudomonas aeruginosa triggers weight loss in rats.Animal models of external traumatic wound infections Effects of intratracheal administration of novispirin G10 on a rat model of mucoid Pseudomonas aeruginosa lung infection Enhanced susceptibility to infections in a diabetic wound healing model.Antimicrobial peptides effectively kill a broad spectrum of Listeria monocytogenes and Staphylococcus aureus strains independently of origin, sub-type, or virulence factor expression Topical antimicrobials for burn infections - an update Topical nanoemulsion therapy reduces bacterial wound infection and inflammation after burn injury.Efficacy of topically delivered moxifloxacin against wound infection by Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance?Antimicrobial peptide killing of African trypanosomes.A short artificial antimicrobial peptide shows potential to prevent or treat bone infections.Host defense peptides in wound healing.Bioengineered human skin: working the bugs out.Antiseptics in surgery Novispirin G10-induced lung toxicity in a Klebsiella pneumoniae infection model.Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections.Adding selectivity to antimicrobial peptides: rational design of a multidomain peptide against Pseudomonas spp.Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1.Adenoviral gene delivery to primary human cutaneous cells and burn wounds.Editorial: glycyrrhizin against multi-resistant bacteria?In vivo comparison of Dhvar-5 and gentamicin in an MRSA osteomyelitis prevention model.Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds.

P2860

Q24803217-B8F6D2DF-BB54-4C70-BAB9-E58FCF58DFC9 Q24814363-7338809E-9AD2-485B-BB93-EF3073365A46 Q28391960-90253CA7-07A0-4C35-9976-F78631C0EC26 Q33222432-F74F6654-18F5-4550-9F11-E80C38C3CD0F Q33321948-898B0215-2F2D-42DF-918F-3A43EF31FB85 Q33387444-23145F9F-55AF-4F6A-87AB-F7C6351367AA Q33600002-DA71F616-44C9-4239-8794-F5783AF7BBA1 Q33937803-0AAA4891-48F2-4D31-AEB3-28CDF34107FE Q34932409-E3C1EF1B-3DF2-4347-B28F-7A656A0F9799 Q35010044-E9A85D16-B1A3-4F1E-AD3A-4D1608900702 Q35112654-BC745DE5-1517-475B-A9AC-543947416ED6 Q36363761-42147A38-E45A-4309-8AF3-02259F95077F Q37127271-9094E6F4-3B6B-4BF5-9A4F-09E848D3EF37 Q39505016-A180C9F0-B6EA-4FFA-9D85-A9EFF233A18D Q39866579-388966DB-A631-44BA-93E3-650AA8120122 Q40345327-506E3571-CF43-4F66-9F0D-443F73E5D5BA Q40405905-42BB01D7-2F37-43FD-B647-9D61CA3BAE8E Q41973626-2C26A774-8BF4-4041-B1CF-8707C627BF91 Q42589056-8F83BEC0-C7B3-4F1E-8144-911EA013CE97 Q43011068-7B3ED642-7ADE-41FC-BAE6-061D5172D812 Q43202717-C935E50D-AC77-4686-8D80-EDABD4283C2F Q45146805-04A469B5-E3E3-4C44-B2DE-DF978FB817AC Q52592947-7D5FED89-FC85-4F51-B206-C9E37A654630

P2860

Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.

http://www.wikidata.org/entity/Q34108244

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

name

Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.

@ast

Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.

@en

Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.

@nl

type

label

Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.

@ast

Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.

@en

Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.

@nl

prefLabel

Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.

@ast

Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.

@en

Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.

@nl

P1433

Q34108244-50B1F4B7-5C04-4E59-A8FD-F67D2EA6E586

P1476

Q34108244-6E624667-ECB3-4A86-8718-A0104EC6E32F

P2093

Q34108244-037FCA17-CC5D-43A8-B3A3-3C9D86D0491C

Q34108244-15282462-F28F-4324-ACFC-12291EAA4BC9

Q34108244-42BEF842-BED8-42F5-B4A7-4E5B157F96D3

Q34108244-7CCA9A30-54AD-4DA7-831E-11B0AAE25D94

Q34108244-C071D0BC-10D5-411D-902C-B642A280AD74

Q34108244-C57941CC-73CA-4A69-A461-70EEEB6FDCA6

Q34108244-CB44F886-2823-43BC-893C-E77056AEA9FB

Q34108244-E226FC27-6FBC-41B9-921B-90E008985F7C

Q34108244-E69BB093-FB41-4D90-A226-9E28655694CA

Q34108244-EEAEC86E-EA51-4AC0-9E03-F3D565A66595

P2860

Q34108244-005AA7D1-8443-48E5-9E73-2FFCEB1B82DA

Q34108244-00BB8E26-F953-4360-81DF-C43BA89CE275

Q34108244-077F15A4-E27B-4EEF-B552-4EDED5C9F84A

Q34108244-09B7D72F-041C-4F4B-85EE-B28AD12094AC

Q34108244-121199D0-0208-4AFC-88F6-7FE39047898D

Q34108244-1B272A2D-DD63-4F07-A292-35BFD8D0EFD9

Q34108244-260278A0-47D1-4EE8-BCF9-6DC6CBF7EF86

Q34108244-2A6D8F23-B67C-43CE-B05B-FF4F2AB5B1E4

Q34108244-2D911A33-5442-4C90-8117-BCB87BBAD984

Q34108244-34A627F6-4D9B-4DF8-B1E1-DD1DDFB2FD0E

P304

Q34108244-F6849D09-DB50-4431-BE0C-D3492E9FBEBB

P31

Q34108244-E94E7457-3188-4A71-A6AC-08E9B309E4E1

P356

Q34108244-6FDA8D03-40A7-4C31-9894-DE72F171B3FC

P407

Q34108244-5C97376F-61CC-4B34-A3FF-D19112DC340E

P433

Q34108244-E05D9C23-9245-4FE3-B87E-DA72D455AE02

P478

Q34108244-C06D0E73-76D8-4D13-B3E7-4A8316E8A27C

P577

Q34108244-40122151-0626-4870-AABF-E1D209CCD8E9

P5875

Q34108244-98157EA1-D267-4B95-9782-094E5770C1BB

P698

Q34108244-E1361792-1FCD-4F7B-AD89-5AFCC05878DF

P921

Q34108244-F86E8A55-25E7-45DB-A567-268FA5A5059F

P932

Q34108244-84B13416-20AC-417C-805F-E06292F4B707

P356

AAC.46.6.1837-1844.2002

P1433

Antimicrobial Agents and Chemotherapy

P1476

Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.

@en

P2093

Alan J Waring

http://www.w3.org/2001/XMLSchema#string

Brian F Tack

http://www.w3.org/2001/XMLSchema#string

Daniel I Remick

http://www.w3.org/2001/XMLSchema#string

Grace L Su

http://www.w3.org/2001/XMLSchema#string

Lars Steinstraesser

http://www.w3.org/2001/XMLSchema#string

Lee M Boo

http://www.w3.org/2001/XMLSchema#string

Ming-Hui Fan

http://www.w3.org/2001/XMLSchema#string

Robert I Lehrer

http://www.w3.org/2001/XMLSchema#string

Stewart C Wang

http://www.w3.org/2001/XMLSchema#string

Teresa Hong

http://www.w3.org/2001/XMLSchema#string

P2860

Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells

FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis

Activity of protegrins against yeast-phase Candida albicans

Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria

Human beta-defensin-2

Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse

Orientation and dynamics of an antimicrobial peptide in the lipid bilayer by solid-state NMR spectroscopy.

CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity.

Complementary DNA sequence of rabbit CAP18--a unique lipopolysaccharide binding protein.

P304

1837-1844

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.46.6.1837-1844.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11352900

http://www.w3.org/2001/XMLSchema#string

P698

12019098

http://www.w3.org/2001/XMLSchema#string

P921

Pseudomonas aeruginosa

P932

127209

http://www.w3.org/2001/XMLSchema#string